Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-25 | New | $28,548,588 | $28,548,588 | Equity Only | 06b | SEC link |
| 2024-07-24 | Amended | $22,486,953 | $19,279,903 | Equity and Debt | 06b | SEC link |
| 2022-08-16 | New | $3,207,050 | $3,207,050 | Equity and Debt | 06b | SEC link |
| 2021-11-02 | New | $3,490,000 | $3,490,000 | Equity and Debt | 06b | SEC link |
| 2020-09-28 | New | $3,021,475 | $3,021,475 | Debt Only | 06b | SEC link |
| 2018-07-02 | New | $1,561,500 | $1,561,500 | Debt Only | 06b | SEC link |
| 2016-11-10 | Amended | $1,072,281 | $979,128 | Equity Only | 06b | SEC link |
| 2016-09-20 | New | $93,153 | $93,153 | Equity Only | 06b | SEC link |
| 2016-04-14 | New | $11 | $11 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Abbas Ardehali, M.D. | Director |
| Alex Arrow | Director |
| Jim Buck | Director, Executive |
| Matthew Dowling | Director, Executive |
| Matthew Dowling, Ph.D | Director, Executive |
| Peter Thomas | Director, Executive |
| Larry Tiffany | Director, Executive |
| Rich Vincent | Executive |